Search Results 1011-1020 of 29640 for thyroid
The purpose of this study is to evaluate response, survival, safety, and tolerability of treatment with lenvatinib for patients who have anaplastic thyroid ...
... thyroid eye disease or Graves' ophthalmopathy — for many years. That tradition of innovation in research of thyroid disorders continues today. Mayo Clinic ...
"Hypothyroidism is when the thyroid is making inadequate amounts of thyroid hormone." If you have an underactive thyroid gland, the symptoms may not be ...
Marius N. Stan, M.D., is primarily working in the area of autoimmune thyroid diseases, with a specific interest in Graves' disease and Graves' ophthalmopathy. A ...
Learn about the symptoms, causes and treatment of this immune system condition that results in too much thyroid hormone.
The purpose of this study is to evaluate the efficacy of batoclimab 680 milligrams (mg) subcutaneous (SC) once a week (QW) for 12 weeks followed by 340 mg SC QW ...
Mayo Clinic researcher Juan P. Brito Campana, M.B.B.S., is an endocrinologist and a healthcare expert with a subspecialty in thyroid cancer.
Research. Mayo Clinic has been researching and treating Graves' disease and its associated eye-related changes — called thyroid eye disease or Graves' ...
The purpose of this study is to determine how well cabozantinib, nivolumab, and ipilimumab work in treating patients with differentiated thyroid cancer that ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.